This issue of the journal presents a milestone in expanding coverage against cancers
associated with human papillomavirus (HPV). Joura and coauthors' report of a randomized …

Human papillomavirus (HPV) is the most common sexually transmitted infectious agent; its
14 oncogenic types are causally associated with 5–10% of all cancers. The major structural …

The availability of a “cancer vaccine” has elicited enormous enthusiasm from the medical
community and the public, culminating in advocacy for mandatory vaccination against …

Genital human papillomavirus (HPV) infection and HPV‐associated cervical and other
anogenital cancers are significant public health problems. HPV 16 and HPV 18 are …

Globally, human papillomavirus (HPV) infection is one of the most common sexually
transmitted infection. HPV is linked to at least five malignancies including vulvar, vaginal …

Despite great expectations and promising results of clinical trials, we still lack sufficient
evidence of an effective vaccine against cervical cancer. Several strains of human …

Human Papillomavirus (HPV) infection causes cervical cancer, a significant portion of anal,
vulvar, vaginal, and oropharyngeal cancers, genital warts, and recurrent respiratory …

CERVICAL CANCER IS THE SECOND MOST COMMON CAN-cer among women globally,
according to age-standardized incidence rates. 1 Approximately 530 000 women are …

Vaccine Trial population, which was comprised largely of sexually active women aged 18–
25 years. Also, as noted by the authors, these results from a trial of the bivalent HPV16/18 …

440 Editorials| JNCI Vol. 101, Issue 7| April 1, 2009 to vaccination. This study was conducted
before vaccine introduction, and the authors posit that the change was due to increases in …